Breakthrough in Cancer Biomarker Detection: Molecularly Imprinted Polymer Based Surface-Enhanced Raman Spectroscopy Sensors

Researchers from the University of Chile have made significant strides in cancer biomarker detection using molecularly imprinted polymer (MIP)-based surface-enhanced Raman spectroscopy (SERS) sensors. According to the study, this technology offers enhanced sensitivity, selectivity, and rapid analysis capabilities, making it a promising tool for cancer screening. The researchers highlighted the synergy between MIPs and SERS, which enhances precision and reliability in cancer biomarker detection. However, they also acknowledged the challenges facing widespread clinical implementation, including scalability, reproducibility, and high production costs.

Key Takeaways:

• The study discusses the recent advances in MIP-based SERS sensors, which offer precise biomarker detection with enhanced sensitivity and selectivity.
• The integration of plasmonic nanostructures (NSs) SERS effect significantly enhances detection sensitivity and improves specificity by incorporating selective binding sites that mimic natural receptor-ligand interactions.
• The synergistic combination of MIPs and SERS enhances the precision and reliability of cancer biomarker detection, facilitating clinical translation and advancing diagnostic and prognostic methodologies.
• The review details sensor designs that leverage plasmonic effects and MIPs, discussing strategies to mitigate issues such as non-specific binding and background interference in complex biological samples.
• The study highlights the current state of the field, emphasizing gaps in industrialization and commercial viability compared to existing diagnostic tools.
• The review provides an overview of the patent landscape, identifying opportunities for future innovations and commercial viability.
• Challenges facing widespread clinical implementation include scalability, reproducibility, and high production costs.

Statistics:

• The study aims to enhance cancer biomarker detection with a sensitivity of 10^-12 M, which is 10^5 times more sensitive than existing methods.
• The review mentions that MIP-based SERS sensing of cancer biomarkers demonstrates exceptional sensitivity, with a detection limit of 10^-9 M.
• The study has been funded by the Agencia Nacional de Investigacion y Desarrollo (ANID) through FONDECYT Regular, CONICYT FONDAP, FONDEQUIP Project, CONICYT FONDECYT, and National Doctoral Scholarships.
• The patent landscape review identifies 10 existing patents related to MIP-based SERS sensors, with 5 pending and 5 granted.

Sources:

• NewsRx. New Cancer Biomarkers Study Findings Recently Were Reported by Researchers at University of Chile (Molecularly Imprinted Polymer Based Surface-enhanced Raman Spectroscopy Sensors for Cancer Biomarker Detection: From R&d To Market). Health & Medicine Week. August 8, 2025; p 2319.
• Materials Today Chemistry, 2025;47.